The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Remember, you're going to make antibodies against multiple portions of the Coronavirus. And so your chances of getting an antibody that might be directed against something in your body is higher when you have more epitopes, like you would with a natural infection with COVID-19, than you would against a very specific portion of a very specific protein of SARS-CoV-2, which is the spike protein.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.